Individualized anticoagulation management and improvement of the safety and
effectiveness of oral anticoagulant have always been the focus of clinicians' attention. D …

Background Integrated care for the clinical management of atrial fibrillation patients is
advocated as a holistic way to improve outcomes; the simple Atrial fibrillation Better Care …

Risk assessments are an important element in the management of patients with atrial
fibrillation (AF). In this review, we aim to discuss the concepts and controversies surrounding …

Until recently, vitamin K antagonists (VKAs) were the mainstay of oral anticoagulant
treatment with bleeding as the most prevalent adverse effect. One to four percent of patients …

Introduction Routine monitoring is not required in direct oral anticoagulant (DOAC)
treatment, yet it is frequently performed. Guidance on the interpretation and management of …

Background Vitamin K antagonist (VKA) therapy is safer and more effective when patients
have a high time within the therapeutic range and low international normalised ratio …

Background There is a high prevalence of atrial fibrillation (AF) in patients undergoing
haemodialysis. Oral anticoagulant therapy with vitamin K antagonists (VKAs) is the only …

The evidence of direct oral anticoagulants (DOACs) usage for venous thromboembolism
(VTE) in patients at extremes of body weight or mass index is limited. In such situations …

Background Clinical pharmacy anticoagulation services have improved the quality of
anticoagulant therapy and are associated with lower rates of bleeding and …

Aims We sought to investigate the association between sex and oral anticoagulation control
employing coumarin derivatives. Methods Electronic sources were MEDLINE, Biblioteca …